Mark E. Delaney's most recent trade in Quest Diagnostics, Inc. was a trade of 5,682 Common Stock done at an average price of $204.9 . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics | Mark E. Delaney | SVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 204.86 per share. | 04 Mar 2026 | 5,682 | 14,190 (0%) | 0% | 204.9 | 1,164,015 | Common Stock |
| Quest Diagnostics | Mark E. Delaney | SVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 204.86 per share. | 04 Mar 2026 | 2,326 | 11,864 (0%) | 0% | 204.9 | 476,504 | Common Stock |